There is no Press for this Ticker
H. Lundbeck A/S is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system, or CNS, drugs worldwide, including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, and Vyepti for migraine prevention. The majority of the company's product sales are derived in the North American region.

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
HLUYYH. Lundbeck-11.58%6.3B

H. Lundbeck Company Questions & Answers

Q

How do I buy H. Lundbeck (HLUYY) stock?

A

You can purchase shares of H. Lundbeck (OTC: HLUYY) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are H. Lundbeck's (HLUYY) main competitors?

A

There are no as such competitors for H. Lundbeck.

Q

What is the target price for H. Lundbeck?

A

The latest price target for H. Lundbeck (OTC: HLUYY) was reported by Leerink Swann on 2018-11-13. The analyst firm set a price target for 0.00 expecting HLUYY to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

How much is H. Lundbeck (HLUYY) stock ?

A

The stock price for H. Lundbeck (OTC: HLUYY) is $31.62 last updated Tue Apr 13 2021 19:33:47 GMT+0000 (Coordinated Universal Time).

Q

When is the next H. Lundbeck (HLUYY) dividend?

A

There are no upcoming dividends for H. Lundbeck.

Q

When is H. Lundbeck (OTC:HLUYY) reporting earnings?

A

There are no earnings for H. Lundbeck

Q

When is the upcoming split for HLUYY?

A

There is no upcoming split for H. Lundbeck.